APA (7th ed.) Citation

N, K., A, N., D, L., E, P., S, R., J, F., . . . GY, O. (2023). Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy. Journal of the American Heart Association, 12(21), e030229. https://doi.org/10.1161/JAHA.123.030229

Chicago Style (17th ed.) Citation

N, Kashyap, et al. "Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy." Journal of the American Heart Association 12, no. 21 (2023): e030229. https://doi.org/10.1161/JAHA.123.030229.

MLA (9th ed.) Citation

N, Kashyap, et al. "Prognostic Utility of Cardiovascular Magnetic Resonance-Based Phenotyping in Patients With Muscular Dystrophy." Journal of the American Heart Association, vol. 12, no. 21, 2023, p. e030229, https://doi.org/10.1161/JAHA.123.030229.